Jade Biosciences, Inc. - Common Stock, $0.0001 par value per share (JBIO)

Historical Holders from Q2 2025 to Q3 2025

Symbol
JBIO on Nasdaq
CUSIP
008064206
Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
33M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
31.6M
Holdings value
$273M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
74
Number of buys
29
Number of sells
-26
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Jade Biosciences, Inc. - Common Stock, $0.0001 par value per share (JBIO)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Fairmount Funds Management LLC 19.99% 0% $89.4M $26.8M 10.4M +42.8% Fairmount Funds Management LLC Oct 6, 2025
FMR LLC 14.7% $41M 4.74M FMR LLC May 30, 2025
Venrock Healthcare Capital Partners III, L.P. 9.9% 3.22M Venrock Healthcare Capital Partners III, L.P. Apr 28, 2025
RA CAPITAL MANAGEMENT, L.P. 7% +72.5% $27.8M $16.3M 3.21M +143% RA Capital Management, L.P. Oct 8, 2025
Deep Track Capital, LP 6.99% -18.3% $19.7M -$4.36M 2.28M -18.1% Deep Track Capital, LP Sep 30, 2025
BlackRock, Inc. 6.6% +26% $18.6M $3.76M 2.15M +25.4% BlackRock, Inc. Sep 30, 2025
VANGUARD GROUP INC 5.6% $15.6M 1.81M The Vanguard Group Jun 30, 2025
Frazier Life Sciences Public Fund, L.P. 4.2% 0% $11.9M $379K 1.38M +3.28% Frazier Life Sciences Public Fund, L.P. Sep 30, 2025
TCG Crossover GP I, LLC 0.2% 64K TCG Crossover GP I, LLC Apr 28, 2025
Atlas Venture Fund XII, L.P. 0.2% 51.4K Atlas Venture Associates XII, L.P. Apr 28, 2025

Institutional Holders of Jade Biosciences, Inc. - Common Stock, $0.0001 par value per share (JBIO)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 31.6M $273M +$407K $8.63 74
2025 Q2 31.5M $315M +$315M $9.99 70